Correct Answer: C. Infection
Infection is the most common triggering factor for erythema multiforme (EM), the condition being referenced. Herpes simplex virus (HSV) is the single most frequent infectious trigger, accounting for 50–90% of recurrent EM cases in Indian populations. Other common infectious triggers include Streptococcus pyogenes (post-streptococcal EM), Mycoplasma pneumoniae, and tuberculosis—particularly relevant in India given the TB burden. The pathophysiology involves immune complex deposition (Type III hypersensitivity) and T-cell-mediated responses (Type IV) at the dermal–epidermal junction, triggered by microbial antigens or their cross-reactive epitopes. HSV-specific CD8+ T cells infiltrate lesional skin even in the absence of active viral replication, suggesting a memory-driven response. In Indian clinical practice, post-streptococcal EM remains common in children, while HSV-associated EM predominates in adults. The temporal relationship between infection and EM onset (typically 1–3 weeks post-infection) is diagnostically significant and guides management toward treating the underlying infection rather than immunosuppression alone.
Why the other options are wrong
A. Drugs — While drug-induced EM is well-documented (sulfonamides, NSAIDs, anticonvulsants, antibiotics), it accounts for only 10–15% of EM cases. Infection remains 5–10 times more common as a trigger. The NBE trap here exploits students' familiarity with drug-induced cutaneous reactions, but infection-triggered EM is far more prevalent in Indian clinical settings. B. Vaccination — Vaccination is a rare trigger for EM, reported in isolated case reports but not a recognized common cause. This option may trap students who confuse EM with other post-vaccination adverse events (e.g., vasculitis). The epidemiological data overwhelmingly support infection as the primary trigger in both developed and Indian populations. D. Malignancy — Malignancy-associated EM is exceptionally rare and typically occurs in advanced or paraneoplastic settings. It is not a recognized common triggering factor. This option may mislead students who recall rare case reports but fail to recognize that infection (especially HSV and streptococcal) dominates the epidemiology of EM in Indian clinical practice.
High-Yield Facts
- HSV is the single most common infectious trigger of EM, accounting for 50–90% of recurrent cases and 30–50% of initial presentations in India.
- Post-streptococcal EM is the second most common infection-triggered form, particularly in children; Group A Streptococcus (GAS) remains endemic in Indian populations.
- Mycobacterium tuberculosis is an underrecognized trigger of EM in India; TB-associated EM may present with systemic symptoms and requires anti-TB therapy.
- Drug-induced EM accounts for only 10–15% of cases; sulfonamides and NSAIDs are the most common culprits but are far less frequent than infection.
- The temporal lag between infection and EM onset is typically 1–3 weeks, reflecting immune complex formation and T-cell sensitization rather than direct viral cytopathology.
Mnemonics
HSM for EM Triggers Herpes (HSV) — most common; Streptococcus — second; Mycoplasma/Mycobacterium — third. Infection dominates; drugs/malignancy are rare.
NBE Trap
NBE pairs drug-induced reactions with EM to exploit students' familiarity with iatrogenic cutaneous disease, but epidemiological data show infection (especially HSV and streptococcal) is 5–10 times more common. The trap is recognizing that while drugs can cause EM, they are not the most common trigger.
Clinical Pearl
In Indian outpatient dermatology, a child presenting with target lesions and a history of recurrent cold sores or recent sore throat should prompt immediate HSV serology or streptococcal throat culture. Treating the underlying infection (acyclovir for HSV, antibiotics for GAS) often resolves EM without need for systemic corticosteroids, reducing morbidity in resource-limited settings.
_Reference: Robbins Ch. 25 (Skin); Harrison Ch. 56 (Erythema Multiforme); Park's Textbook of Preventive and Social Medicine (epidemiology of streptococcal infections in India)_